Drug intelligence / Profile preview

Xiao'er Feire Keshan oral liquid

Development stage: Unknown
Lead developer: Sunflower Pharmaceutical Group
Administration: Oral

Overview

Xiao'er Feire Keshan oral liquid is a Traditional Chinese Medicine (TCM) formulation developed by Heilongjiang Kuihua Pharmaceutical for pediatric respiratory conditions. It is primarily indicated for the treatment of acute bronchitis, specifically cases characterized by the "wind-heat invading the lung" pattern in TCM theory. The formulation is designed to clear heat, detoxify the lungs, and relieve symptoms such as cough and asthma. It is currently being evaluated in Phase II clinical trials in China to assess its safety and efficacy in children aged 1 to 14 years, comparing the standard formulation against ultra-low dose versions.

Brand names: Xiao'er Feire Keshan oral liquid
Other names: Xiao'er Feire Kechuan oral liquidPediatric Feire Keshan Oral Liquid

Beyond the preview

Go deeper on Xiao'er Feire Keshan oral liquid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiao'er Feire Keshan oral liquid.

Explore the full profile